CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 50 enrolled
Drug / intervention
Ezetimibedrug
Likely dose
Ezetimibe 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01766713
NCT01766713Phase 2Completed
CompareCT.gov

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

University of California, San Diego·interventional·Posted Jan 11, 2013·Updated Jul 14, 2020

In Brief

A Phase 2 clinical trial evaluating Ezetimibe for Non Alcoholic Steatohepatitis. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of the study is to see if the drug ezetimibe is a potential treatment for Nonalcoholic Steatohepatitis(NASH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon Alcoholic Steatohepatitis
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 11, 2013
Enrollment StartJan 1, 2013
Primary CompletionAug 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 13.5 years ago

Interventions

Ezetimibedrug

10mg daily oral dose of ezetimibe